Smartphone app aims to capture cancer patients' diets during radiation

NCT ID NCT07682714

Recruiting now Knowledge-focused Sponsor: University of Minnesota Source: ClinicalTrials.gov ↗

First seen Jul 06, 2026 · Last updated Jul 15, 2026 · Updated 5 times

Summary

This study tests whether cancer patients undergoing radiation therapy can use a mobile app called myCircadian Clock to record everything they eat and drink (except water and medications). Twenty adults starting radiation for cancer will use the app throughout their treatment. The goal is to see if at least 75% of participants can log their diet on at least 80% of treatment days, which would show that this method is practical for future research.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: myCircadian Clock app
What this could lead to: If successful, this could show that a simple mobile app is a practical way to track diet in cancer patients during radiation, helping researchers better understand nutrition needs.
What could go wrong: This is a small feasibility study with only 20 participants, so results may not apply to everyone. The app relies on patients remembering to log their food, which may be difficult during treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER DIETARY INTAKE RADIATION THERAPY

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University Of Minnesota
RECRUITING

Minneapolis, Minnesota, 55455, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.